Valved Graft Post-Market Clinical Follow-up Study
Status: Recruiting
Location: See all (25) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement
Locations
United States
Alabama
University Hospital - Univ. of Alabama at Birmingham (UAB)
WITHDRAWN
Birmingham
Michigan
University of Michigan
RECRUITING
Ann Arbor
North Carolina
Mission Health & Hospitals
WITHDRAWN
Asheville
Pennsylvania
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
University of Pittsburgh Medical Center
RECRUITING
Pittsburgh
Other Locations
Austria
Klinik Floridsdorf
RECRUITING
Vienna
Denmark
Rigshospitalet
RECRUITING
Copenhagen
France
CHU de Besancon - Jean Minjoz
RECRUITING
Besançon
CHRU Lille
RECRUITING
Lille
Groupe Hospitalier Bichat - Claude Bernard
RECRUITING
Paris
Germany
Herz-und Diabetes Zentrum NRW
RECRUITING
Bad Oeynhausen
Deutsches Herzzentrum Berlin
RECRUITING
Berlin
Klinikum Links der Weser
RECRUITING
Bremen
Medizinische Hochschule Hannover
RECRUITING
Hanover
Greece
Onassis Cardiac Surgery Center
RECRUITING
Athens
Italy
Policlinico S.Orsola-Malpighi
RECRUITING
Bologna
Ospedale San Raffaele
RECRUITING
Milan
Policlinico San Donato
RECRUITING
San Donato Milanese
Poland
Wojewodzki Szpital Zespolony w Kielcach
WITHDRAWN
Kielce
Krakowski Szpital Specjalistyczny im. Jana Pawla II
RECRUITING
Krakow
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
ACTIVE_NOT_RECRUITING
Lodz
The Cardinal Stefan Wyszynski Institute of Cardiology
RECRUITING
Warsaw
Spain
Hospital Universitario del Vinalopó
RECRUITING
Elche
Hospital Universitario Son Espases
RECRUITING
Palma De Mallorca
United Kingdom
James Cook University Hospital
RECRUITING
Middlesbrough
Contact Information
Primary
Paolo Amato
paolo.amato@abbott.com
+39 335 61 40 573
Backup
Karine Miquel
karine.miquel@abbott.com
+32 479 60 01 07
Time Frame
Start Date: 2021-07-13
Estimated Completion Date: 2029-09
Participants
Target number of participants: 260
Treatments
Group 1
VAVGJ
Group 2
CAVGJ
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices